5-aminolevulinic acid and 18F-FET-PET as metabolic imaging tools for surgery of a recurrent skull base meningioma

Journal of Neurological Surgery, Part B: Skull Base

Volumn 74, Issue 4, 2013, Pages 211-216

  Cornelius, Jan Frederick ^a   Slotty, Philipp Jörg ^a   Stoffels, Gabriele ^b   Galldiks, Norbert ^b   Langen, Karl Josef ^b   Steiger, Hans Jakob ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

endoscopic; FET PET; fluorescence guided resection; recurrent meningioma; skull base

Indexed keywords

AMINOLEVULINIC ACID; CEFAZOLIN; DEXAMETHASONE; FLUOROETHYLTYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRACRANIAL TUMOR; INTRAOPERATIVE PERIOD; MENINGIOMA; MENTAL HEALTH; MULTIPLE SCLEROSIS; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; SKULL BASE MENINGIOMA;

EID: 84880525708     PISSN: 2193634X     EISSN: 21936331     Source Type: Journal    
DOI: 10.1055/s-0033-1342918     Document Type: Article

References (12)

1. Ewelt C., Floeth F. W., Felsberg J., et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg: 2011; 113 7 541 547
2. Floeth F. W., Sabel M., Ewelt C., et al. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging: 2011; 38 4 731 741
3. Stummer W., Pichlmeier U., Meinel T., Wiestler O. D., Zanella F., Reulen H. J. ALA-Glioma Study Group Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol: 2006; 7 5 392 401
4. Cornelius J. F., Langen K. J., Stoffels G., Hänggi D., Sabel M., Steiger H. J. PET IMAGING OF MENINGIOMA IN CLINICAL PRACTICE: Review of literature and future directions. Neurosurgery: 2011; Oct
5. Gehler B., Paulsen F., Oksüz M. O., et al. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol: 2009; 4 56
6. Astner S. T., Dobrei-Ciuchendea M., Essler M., et al. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys: 2008; 72 4 1161 1167
7. Eljamel M. S., Leese G., Moseley H. Intraoperative optical identification of pituitary adenomas. J Neurooncol: 2009; 92 3 417 421
8. Coluccia D., Fandino J., Fujioka M., Cordovi S., Muroi C., Landolt H. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. Acta Neurochir (Wien): 2010; 152 10 1711 1719
9. Plotkin M., Blechschmidt C., Auf G., et al. Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas. Eur Radiol: 2010; 20 10 2496 2502
10. Stummer W., Tonn J. C., Mehdorn H. M., et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg: 2011; 144 3 613 623
11. Kajimoto Y., Kuroiwa T., Miyatake S., et al. Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. J Neurosurg: 2007; 106 6 1070 1074
12. Hefti M. Comment concerning: Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas, Acta Neurochir DOl 1O.1007/s00701-010-0708-4, Intratumoral heterogeneity and fluorescence intensity in meningioma after 5-ALA pretreatment. Acta Neurochir (Wien): 2011; 153 4 959 960